v3.26.3
Condensed Consolidated Statements of Changes in Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Balance (in shares) at Dec. 31, 2024   15,617 11,012,105      
Balance at Dec. 31, 2024 $ 62,607   $ 11 $ 156,328 $ 3 $ (93,735)
Stock-based compensation 1,094     1,094    
Exercise of common stock options for cash, net of expense (in shares)     9,284      
Exercise of common stock options for cash, net of expense 67     67    
Foreign currency translation gain (loss) (6)       (6)  
Net Income (Loss) (8,185)         (8,185)
Balance (in shares) at Mar. 31, 2025   15,617 11,021,389      
Balance at Mar. 31, 2025 55,577   $ 11 157,489 (3) (101,920)
Balance (in shares) at Dec. 31, 2024   15,617 11,012,105      
Balance at Dec. 31, 2024 62,607   $ 11 156,328 3 (93,735)
Unrealized gain (loss) on investments 0          
Net Income (Loss) (29,001)          
Balance (in shares) at Sep. 30, 2025   15,617 11,088,329      
Balance at Sep. 30, 2025 38,682   $ 11 161,303 104 (122,736)
Balance (in shares) at Mar. 31, 2025   15,617 11,021,389      
Balance at Mar. 31, 2025 55,577   $ 11 157,489 (3) (101,920)
Stock-based compensation 1,433     1,433    
Exercise of common stock options for cash, net of expense 349   $ 38,276 349    
Foreign currency translation gain (loss) (108)       (108)  
Net Income (Loss) (9,471)         (9,471)
Balance (in shares) at Jun. 30, 2025   15,617 11,059,665      
Balance at Jun. 30, 2025 47,780   $ 11 159,271 (111) (111,391)
Stock-based compensation 1,790     1,790    
Exercise of common stock options for cash, net of expense (in shares)     28,664      
Exercise of common stock options for cash, net of expense 242     242    
Foreign currency translation gain (loss) 215       215  
Unrealized gain (loss) on investments 0          
Net Income (Loss) (11,345)         (11,345)
Balance (in shares) at Sep. 30, 2025   15,617 11,088,329      
Balance at Sep. 30, 2025 38,682   $ 11 161,303 104 (122,736)
Balance (in shares) at Dec. 31, 2025     12,380,933      
Balance at Dec. 31, 2025 27,983   $ 12 163,338 83 (135,450)
Issuance of common stock (in shares)     1,840,000      
Issuance of common stock 215,753   $ 2 215,751    
Stock-based compensation 3,376     3,376    
Exercise of common stock options for cash, net of expense (in shares)     92,726      
Exercise of common stock options for cash, net of expense 956     956    
Foreign currency translation gain (loss) 8       8  
Unrealized gain (loss) on investments 4       4  
Net Income (Loss) (15,767)         (15,767)
Balance (in shares) at Mar. 31, 2026     14,313,659      
Balance at Mar. 31, 2026 232,313   $ 14 383,421 95 (151,217)
Balance (in shares) at Dec. 31, 2025     12,380,933      
Balance at Dec. 31, 2025 27,983   $ 12 163,338 83 (135,450)
Unrealized gain (loss) on investments (40)          
Net Income (Loss) (62,280)          
Balance (in shares) at Sep. 30, 2026     14,607,244      
Balance at Sep. 30, 2026 197,924   $ 15 395,583 56 (197,730)
Balance (in shares) at Mar. 31, 2026     14,313,659      
Balance at Mar. 31, 2026 232,313   $ 14 383,421 95 (151,217)
Stock-based compensation $ 5,155     5,155    
Issuance of common Stock upon settlement of employee performance stock units and restricted stock units, net of shares withheld for taxes 3,250   2,293      
Exercise of common stock options for cash, net of expense (in shares)     79,753      
Exercise of common stock options for cash, net of expense $ 1,280     1,280    
Equity issuance costs (5)     (5)    
Foreign currency translation gain (loss) 24       24  
Unrealized gain (loss) on investments (30)       (30)  
Net Income (Loss) (21,870)         (21,870)
Balance (in shares) at Jun. 30, 2026     14,395,705      
Balance at Jun. 30, 2026 216,867   $ 14 389,851 89 (173,087)
Stock-based compensation $ 5,416     5,416    
Issuance of common Stock upon settlement of employee performance stock units and restricted stock units, net of shares withheld for taxes 3,250   2,312      
Exercise of common stock options for cash, net of expense (in shares)     40,726      
Exercise of common stock options for cash, net of expense $ 452     452    
Settlement of performance stock units (136)     (136)    
Conversion of prefunded warrants into common stock (in shares)     168,501      
Conversion of prefunded warrants into common stock 1   $ 1      
Foreign currency translation gain (loss) (19)       (19)  
Unrealized gain (loss) on investments (14)       (14)  
Net Income (Loss) (24,643)         (24,643)
Balance (in shares) at Sep. 30, 2026     14,607,244      
Balance at Sep. 30, 2026 $ 197,924   $ 15 $ 395,583 $ 56 $ (197,730)